SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016483
Filing Date
2023-05-12
Accepted
2023-05-12 06:08:45
Documents
70
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 857673
2 ex10-73.htm EX-10.73 408640
3 ex10-74.htm EX-10.74 95099
4 ex31-1.htm EX-31.1 23061
5 ex32-1.htm EX-32.1 10796
  Complete submission text file 0001493152-23-016483.txt   5944260

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bixt-20230331.xsd EX-101.SCH 48228
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bixt-20230331_cal.xml EX-101.CAL 47694
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bixt-20230331_def.xml EX-101.DEF 204819
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bixt-20230331_lab.xml EX-101.LAB 343553
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bixt-20230331_pre.xml EX-101.PRE 308991
64 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 805875
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35027 | Film No.: 23913037
SIC: 2834 Pharmaceutical Preparations